In this study, no significant differences were found in serum E2 and FSH change after 12 weeks' intervention, both in 2 groups, which proved that TB had no impact on AIs' curative effect on breast cancer, ensuring the safety of TB treating AIMSS. The gene discussed is BRD2; the disease is breast cancer.